PMS-ATORVASTATIN

Pharmascience Inc🇨🇦 Health Canada

Approval Id: d7e4f2ae29af2cd0
Drug Approval Canada Name: PMS-ATORVASTATIN
Product Name: PMS-ATORVASTATIN
Status: Dormant
Status Date: 2024-07-31
Original Market Date: 2020-04-21
Din: 02477149
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:06.08
Atc Original: C10AA05 ATORVASTATIN
Atc Name: c 10 aa 05
Aig Number: 0133055001
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

ATORVASTATIN (ATORVASTATIN CALCIUM)

10 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d7e4f2ae29af2cd0

Type

Standard